Đang chuẩn bị liên kết để tải về tài liệu:
Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

One of the major causes of mortality all over the world is chronic obstructive pulmonary disease (COPD). Recently approved combined inhaler of formoterol fumarate (FF) and glycopyrronium bromide (GLY) has been used in very low concentrations (µg level/actuation) doses in COPD patients. | Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler

TÀI LIỆU LIÊN QUAN

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma

Controllable optical properties of multiple electromagnetically induced transparency in gaseous atomic media

A state-of-art survey on project selection using MCDM techniques

In-line Fourier-transform infrared spectroscopy as a versatile process analytical technology for preparative protein chromatography

Scalable analysis of Big pathology image data cohorts using efficient methods and high-performance computing strategies

Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array

Determination of diquat in human plasma using high performance liquid chromatography with diode array detector

Behavioral optimization models for multicriteria portfolio selection

Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler